Pulmonary Arterial Hypertension: all 773 studies
Page 7 of 8. Open to participants first (142), then studies with results posted, then the rest; newest registration first within each.
- Trimetazidine in Pulmonary Artery HypertensionStatus unknownNCT02102672Phase 2
- Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial HypertensionCompletedNCT02080533Phase 1/2
- Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin)CompletedNCT02074449
- Comparative PK PD Study in PAH Patients (Fox vs. I-Neb)CompletedNCT02032836Phase 1/2
- Estimation of Pulmonary Vascular Resistance by Contrast EchocardiographyCompletedNCT02028299Not applicable
- Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial HypertensionStatus unknownNCT02023450Early Phase 1
- BEET PAH: a Study to Assess the Effects of Beetroot Juice in Patients With Pulmonary Arterial HypertensionCompletedNCT02000856Not applicable
- NIMS- New Implantable Pump in Pulmonary Arterial Hypertension, a Safety Follow upCompletedNCT01977014
- Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)CompletedNCT01966302Phase 2
- Novel Screening Strategies for Scleroderma PAHCompletedNCT01959815
- Hydroxyurea in Pulmonary Arterial HypertensionWithdrawnNCT01950585Early Phase 1
- National Cohort Study of Idiopathic and Heritable Pulmonary Arterial HypertensionStatus unknownNCT01907295
- Resynchronisation Therapy of Right Ventricle in Pulmonary Arterial HypertensionStatus unknownNCT01905189Not applicable
- Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With SildenafilNo longer availableNCT01897740
- Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for InhalationCompletedNCT01894035
- (-)-Epicatechin and Pulmonary Arterial HypertensionWithdrawnNCT01880866Phase 1
- To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male VolunteersCompletedNCT01864863Phase 1
- Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial HypertensionTerminatedNCT01847716
- Iron Status and Hypoxic Pulmonary Vascular ResponsesCompletedNCT01847352Not applicable
- Obstructive Sleep Apnea (OSA) in Pulmonary Arterial Hypertension (PAH)TerminatedNCT01835080
- Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed TomographyCompletedNCT01829672Not applicable
- Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasEStatus unknownNCT01827059Phase 2
- Tyvaso Dosing and Titration Evaluation: TyTRATE RegistryCompletedNCT01799473
- Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)TerminatedNCT01795950Phase 1
- Patient Reported Outcomes in Pulmonary Arterial HypertensionWithdrawnNCT01792622
- Observational Description of Compliance for the Daily Ventavis Use Via the Insight Program in Class III Pulmonary Arterial Hypertension PatientsCompletedNCT01781052
- Training With Whole Body Vibration Device in Patients With PAHStatus unknownNCT01763112Not applicable
- A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial HypertensionCompletedNCT01757808Phase 1
- Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05TerminatedNCT01725269Phase 2
- A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)TerminatedNCT01725256Phase 2
- Beta Blockers for Treatment of Pulmonary Arterial Hypertension in ChildrenWithdrawnNCT01723371Phase 1/2
- Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension PatientsStatus unknownNCT01712997Phase 3
- Exercise Capacity and Quality of Life in Patients With PPH Receiving Short Term Oral L-Citrulline MalateStatus unknownNCT01683981Early Phase 1
- Adult Congenital Heart Disease Registry (QuERI)CompletedNCT01659411
- Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled IloprostStatus unknownNCT01649739Phase 4
- Symptomatic Pulmonary Arterial Hypertension After Mitral Valve SurgeryCompletedNCT01646541
- Efficacy Study of Cardizem in Pulmonary Arterial HypertensionWithdrawnNCT01645826Not applicable
- Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary HypertensionStatus unknownNCT01637675Phase 2/3
- Eisenmenger Quality Enhancement Research InitiativeCompletedNCT01623492
- Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site PainWithdrawnNCT01615627Phase 4
- Proof of Concept Study of IMMUNOadsorption Therapy in Patients With Idiopathic Pulmonary Arterial HypertensionCompletedNCT01613287Not applicable
- Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed TomographyCompletedNCT01607489Not applicable
- Screening of Pulmonary Arterial Hypertension in BMPR2 Mutation CarriersCompletedNCT01600898
- The Study of Apelin-APJ System on Pulmonary Hypertension Patients and Healthy SubjectsCompletedNCT01590108Phase 1
- An Open Label Access Study For Subjects Who Completed A1481156No longer availableNCT01582438
- Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial HypertensionCompletedNCT01572077Not applicable
- Inhaled Treprostinil for PAH: Open-label ExtensionWithdrawnNCT01557660Phase 3
- Safety and Efficacy of Inhaled Treprostinil in Patients With PAHWithdrawnNCT01557647Phase 3
- Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)CompletedNCT01553721Phase 2
- Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary HypertensionCompletedNCT01548950Not applicable
- Carbon Monoxide Therapy for Severe Pulmonary Arterial HypertensionWithdrawnNCT01523548Phase 1/2
- Peripheral Muscle Microcirculation and Exercise-induced Blood Flow Distribution in Pulmonary Arterial HypertensionCompletedNCT01520493Not applicable
- Revatio Portal-Pulmonary Arterial Hypertension TrialTerminatedNCT01517854Phase 2
- Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral BosentanWithdrawnNCT01508780Phase 4
- Prevalence of Pulmonary Hypertension (PAH) in Patients With ThalassemiaCompletedNCT01496963
- Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion MatchingTerminatedNCT01494896
- Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial HypertensionCompletedNCT01491646
- Smoking: a Risk Factor for Pulmonary Arterial Hypertension?CompletedNCT01484899
- Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial HypertensionStatus unknownNCT01468571Phase 4
- Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT SystemCompletedNCT01468545
- Evaluation of Pulmonary Perfusion Heterogeneity and Compliance in Patients With Pulmonary Hypertension Using Positron Emission Tomography ImagingCompletedNCT01461343Not applicable
- A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 InhibitorWithdrawnNCT01458236Phase 3
- Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)CompletedNCT01457781Phase 2
- Effects of Apelin on the Lung Circulation in Pulmonary HypertensionStatus unknownNCT01457170Not applicable
- Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance ImagingCompletedNCT01451255
- Oral Iron Supplementation in Pulmonary HypertensionCompletedNCT01446848Not applicable
- Pulmonary Hypertension in Interstitial Lung DiseaseCompletedNCT01443598
- Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site PainTerminatedNCT01433328Phase 4
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareCompletedNCT01431326
- Registry for Pulmonary Hypertension in ChinaStatus unknownNCT01417338
- Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy SubjectsCompletedNCT01409122Phase 1
- Drug Use Investigation for VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension)CompletedNCT01406327
- Qutenza®-Remodulin® in Pulmonary Arterial Hypertension PatientsCompletedNCT01393795Phase 2
- Responsiveness of Exercise Tests in Pulmonary Arterial HypertensionCompletedNCT01391104Not applicable
- Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension ProgramCompletedNCT01389206
- Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart DiseaseStatus unknownNCT01383083
- Screening for Sleep Hypoxemia in Pulmonary Arterial HypertensionCompletedNCT01371669
- Measuring Blood Pressure in the Lung Circulation With Sonar Technology (Echo-Doppler)TerminatedNCT01357746Phase 1
- Efficacy of Ventavis Used in Real-life Setting.CompletedNCT01355380
- Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH)WithdrawnNCT01352026Phase 2
- Endothelial Function in Patients With Pulmonary Arterial HypertensionCompletedNCT01317134Not applicable
- Iron Deficiency In Pulmonary HypertensionStatus unknownNCT01288651Phase 4
- Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.CompletedNCT01265888Phase 2
- Drug Interaction Between Ritonavir And SitaxsentanWithdrawnNCT01251848Phase 1
- Effect Of Rifampin On Pharmacokinetics Of SitaxsentanWithdrawnNCT01251835Phase 1
- First-line Bosentan and Sildenafil Combination Therapy for Pulmonary Arterial HypertensionCompletedNCT01247116
- Beta-blockers in i-PAHStatus unknownNCT01246037Phase 1/2
- Persistent Pulmonary Artery Hypertension After Valve ReplacementStatus unknownNCT01238731
- Auto-immunity and Pulmonary Arterial HypertensionCompletedNCT01208792Not applicable
- Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis PatientsWithdrawnNCT01202045
- Prospective Longitudinal Study of Patients With Idiopathic Pulmonary Arterial Hypertension, Family or Taking AnorecticsCompletedNCT01185730Not applicable
- Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA)CompletedNCT01181284
- A Bioavailability Study Comparing Treprostinil Diethanolamine Oral Tablets and Oral Solution in Healthy VolunteersCompletedNCT01172496Phase 1
- Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent FacilitiesCompletedNCT01165476Phase 1
- Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil DiethanolamineCompletedNCT01153386Phase 1
- The Effect of Renal Impairment on the Pharmacokinetics of Oral TreprostinilCompletedNCT01131845Phase 1
- Role of Endothelin-A (ETA) and Endothelin-B (ETB) Receptors in the Vasodilatory Response to Endothelin-3 (ET-3)CompletedNCT01100736Early Phase 1
- Tezosentan in Patients With Pulmonary Arterial HypertensionTerminatedNCT01094067Phase 2
- Dichloroacetate (DCA) for the Treatment of Pulmonary Arterial HypertensionCompletedNCT01083524Phase 1
- Tezosentan in Pulmonary Arterial HypertensionTerminatedNCT01077297Phase 2